Beyfortus 50 MG/0.5 ML syringe 0.5ML
Ended Awarded
- Contract number
- SPE2DB26FM92M
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $25,934
Award facts
- Contract value 100% obligated
- $25,933.82 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $25,933.82 to AmerisourceBergen Drug Corp for the supply of Beyfortus 50 mg/0.5 mL syringes on October 14, 2025, with an ultimate completion date of October 15, 2025. This firm fixed price delivery order was competitively awarded with no set-aside designation and will be performed at the contractor's facility in Conshohocken, Pennsylvania. Beyfortus is a monoclonal antibody indicated for respiratory syncytial virus prevention and represents a specialized pharmaceutical product within the Defense Logistics Agency's medical supply procurement portfolio.
This delivery order is issued under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (SPE2DX) with DLA Troop Support Medical, a comprehensive pharmaceutical prime vendor agreement valued at $999,999,999.00 and running through December 2026. The parent IDC serves as a global pharmaceutical support vehicle enabling the company to supply a vast range of medications, vaccines, and medical supplies to support military healthcare programs and other federal government healthcare systems. AmerisourceBergen Drug Corp's demonstrated capability to fulfill federal medical procurement requirements through competitive award processes, combined with its significant contract portfolio encompassing numerous therapeutic domains, positions the company as a critical vendor for federal medical supply needs across the Defense Health Agency and related federal healthcare systems.
Quick answers
Who was awarded contract SPE2DB26FM92M?
SPE2DB26FM92M was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on October 14, 2025.
How much is contract SPE2DB26FM92M worth?
The government has obligated $25,934 on SPE2DB26FM92M.
Is contract SPE2DB26FM92M an order under another contract?
Yes. SPE2DB26FM92M is a delivery order under SPE2DB20D1109, an indefinite delivery contract.
Was contract SPE2DB26FM92M competed?
The extent of competition for SPE2DB26FM92M was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award